Loading video...
Video Failed to Load
Today, Recursion reports its second quarter financial results and business updates, showing demonstrated progress across partnerships, clinical programs, and financial goals. 🚀 Highlights include: ▪️Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated targets... show more
202,603 views • 1 month ago •via X (Twitter)
0 Comments
No comments available
Comments from the original post will appear here
